Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.190
-0.060 (-2.67%)
At close: Apr 28, 2026, 4:00 PM EDT
2.200
+0.010 (0.46%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Allogene Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -190.89 | -257.59 | -327.27 | -340.41 | -182.05 | |
| Depreciation & Amortization | 12.36 | 13.64 | 14.2 | 14.3 | 10.45 | |
| Asset Writedown & Restructuring Costs | 2.38 | 15.72 | 13.25 | - | - | |
| Loss (Gain) From Sale of Investments | -4.22 | -6.39 | 0.19 | 2.89 | 6.96 | |
| Loss (Gain) on Equity Investments | - | 1.69 | 10.67 | 12.88 | 4.09 | |
| Stock-Based Compensation | 37.64 | 51.74 | 65.95 | 83.6 | 80.82 | |
| Other Operating Activities | 4.36 | 5.69 | 6.58 | 2.33 | -73.13 | |
| Change in Accounts Payable | -1.23 | -0.5 | -7.5 | 4.87 | -0.77 | |
| Change in Unearned Revenue | - | - | - | -0.02 | -38.3 | |
| Change in Other Net Operating Assets | -9.65 | -24.3 | -13.81 | -0.95 | 7.12 | |
| Operating Cash Flow | -149.25 | -200.3 | -237.73 | -220.52 | -184.81 | |
| Capital Expenditures | -0.39 | -0.69 | -1.52 | -5.19 | -21.45 | |
| Investment in Securities | 95.95 | 76.38 | 164.81 | 111.35 | 185.1 | |
| Investing Cash Flow | 95.56 | 75.69 | 163.29 | 106.16 | 163.66 | |
| Issuance of Common Stock | 23.25 | 114.4 | 95.7 | 2.95 | 11.96 | |
| Other Financing Activities | 6.91 | 2.28 | - | - | - | |
| Financing Cash Flow | 30.16 | 116.68 | 95.7 | 2.95 | 11.96 | |
| Net Cash Flow | -23.53 | -7.94 | 21.25 | -111.41 | -9.19 | |
| Free Cash Flow | -149.63 | -200.99 | -239.25 | -225.71 | -206.26 | |
| Free Cash Flow Margin | - | -913609.09% | -251841.05% | -144685.90% | -180.79% | |
| Free Cash Flow Per Share | -0.68 | -1.03 | -1.52 | -1.58 | -1.52 | |
| Levered Free Cash Flow | -80.73 | -99.13 | -134.26 | -111.74 | -85.97 | |
| Unlevered Free Cash Flow | -80.06 | -99.02 | -134.26 | -111.74 | -85.97 | |
| Change in Working Capital | -10.88 | -24.8 | -21.31 | 3.9 | -31.95 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.